These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16697480

  • 21. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
    Galán AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G.
    Transfusion; 2003 Jul; 43(7):885-92. PubMed ID: 12823748
    [Abstract] [Full Text] [Related]

  • 22. Recombinant activated factor VII: mechanisms of action and current indications.
    Franchini M, Lippi G.
    Semin Thromb Hemost; 2010 Jul; 36(5):485-92. PubMed ID: 20632246
    [Abstract] [Full Text] [Related]

  • 23. Recombinant activated factor VII: 30 years of research and innovation.
    Hedner U.
    Blood Rev; 2015 Jun; 29 Suppl 1():S4-8. PubMed ID: 26073368
    [Abstract] [Full Text] [Related]

  • 24. In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia.
    Augustsson C, Persson E.
    Blood; 2014 Nov 13; 124(20):3172-4. PubMed ID: 25232061
    [Abstract] [Full Text] [Related]

  • 25. Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.
    Tranholm M, Kristensen K, Kristensen AT, Pyke C, Røjkjaer R, Persson E.
    Blood; 2003 Nov 15; 102(10):3615-20. PubMed ID: 12869500
    [Abstract] [Full Text] [Related]

  • 26. Variants of recombinant factor VIIa with increased intrinsic activity.
    Persson E.
    Semin Hematol; 2004 Jan 15; 41(1 Suppl 1):89-92. PubMed ID: 14872428
    [Abstract] [Full Text] [Related]

  • 27. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT, Chakroun T, Depasse F, Arzoglou P, Samama MM, Elalamy I.
    Thromb Haemost; 2004 May 15; 91(5):977-85. PubMed ID: 15116259
    [Abstract] [Full Text] [Related]

  • 28. Tissue factor-independent effects of recombinant factor VIIa on hemostasis.
    Weeterings C, Lisman T, de Groot PG.
    Semin Hematol; 2008 Apr 15; 45(2 Suppl 1):S12-5. PubMed ID: 18544417
    [Abstract] [Full Text] [Related]

  • 29. Understanding the therapeutic action of recombinant factor VIIa in platelet disorders.
    Hers I, Mumford A.
    Platelets; 2008 Dec 15; 19(8):571-81. PubMed ID: 19012175
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of action of recombinant activated factor VII: an update.
    Hedner U.
    Semin Hematol; 2006 Jan 15; 43(1 Suppl 1):S105-7. PubMed ID: 16427375
    [Abstract] [Full Text] [Related]

  • 31. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
    Campbell RA, Fischer TH, Wolberg AS.
    Br J Haematol; 2007 Jul 15; 138(1):82-93. PubMed ID: 17555451
    [Abstract] [Full Text] [Related]

  • 32. Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development.
    Jurlander B, Thim L, Klausen NK, Persson E, Kjalke M, Rexen P, Jørgensen TB, Østergaard PB, Erhardtsen E, Bjørn SE.
    Semin Thromb Hemost; 2001 Aug 15; 27(4):373-84. PubMed ID: 11547359
    [Abstract] [Full Text] [Related]

  • 33. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
    Carr ME, Martin EJ, Kuhn JG, Seremetis SV.
    Thromb Haemost; 2003 May 15; 89(5):803-11. PubMed ID: 12719776
    [Abstract] [Full Text] [Related]

  • 34. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
    Szlam F, Taketomi T, Sheppard CA, Kempton CL, Levy JH, Tanaka KA.
    Anesth Analg; 2008 Mar 15; 106(3):719-24, table of contents. PubMed ID: 18292408
    [Abstract] [Full Text] [Related]

  • 35. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB.
    Vox Sang; 2007 May 15; 92(4):281-8. PubMed ID: 17456151
    [Abstract] [Full Text] [Related]

  • 36. Dosing with recombinant factor viia based on current evidence.
    Hedner U.
    Semin Hematol; 2004 Jan 15; 41(1 Suppl 1):35-9. PubMed ID: 14872419
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms.
    Keshava S, Pendurthi UR, Esmon CT, Rao LVM.
    J Thromb Haemost; 2020 Aug 15; 18(8):1911-1921. PubMed ID: 32359012
    [Abstract] [Full Text] [Related]

  • 38. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience.
    Habermann B, Hochmuth K, Hovy L, Scharrer I, Kurth AH.
    Haemophilia; 2004 Nov 15; 10(6):705-12. PubMed ID: 15569165
    [Abstract] [Full Text] [Related]

  • 39. How factor VIIa works in hemophilia.
    Butenas S, Brummel KE, Bouchard BA, Mann KG.
    J Thromb Haemost; 2003 Jun 15; 1(6):1158-60. PubMed ID: 12871314
    [Abstract] [Full Text] [Related]

  • 40. Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
    Antovic JP, Antovic A.
    Thromb Haemost; 2003 Oct 15; 90(4):620-7. PubMed ID: 14515182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.